跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IO-3
首页
药物
IO-3
IO-3
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Perfuming complex, perfuming composition and perfumed aqueous composition of natural origin
US 12290583 B2
申请人: EXPRESSIONS PARFUMEES
优先权: 2021
CN
EP
US
3 件公开
Combination taxoid nanoemulsion with immunotherapy in cancer
US 11497713 B2
申请人: TARGAGENIX INC
优先权: 2017
CN
US
3 件公开
Transdermal patches having a siliconic adhesive matrix stabilized with methacrylic copolymers
US 2006015077 A1
申请人: CILURZO FRANCESCO
优先权: 2002
US
Compositions and methods involving MDA-7 for the treatment of cancer
CN 101166539 B
申请人: UNIV TEXAS
优先权: 2006
CN
Chinese medicinal preparation, preparation and detection method thereof
CN 101209341 B
申请人: WENLONG YANG
优先权: 2006
CN
Palladium-103 and io-125 compound sealed seed source, source core and source core preparation method
CN 101797392 B
申请人: ATOM HIGH TECH CO LTD
优先权: 2010
CN
IRON OXIDE NANOCAPSULES, METHOD OF MANUFACTURING THE SAME, AND MRI CONTRAST AGENT USING THE SAME
US 2013164223 A1
申请人: JEON BONG-SIK
优先权: 2010
US
Dielectric for high density substrate interconnects
US 11552010 B2
申请人: INTEL CORP
优先权: 2017
US
Bimodal imaging mediated treatment system for myocardial infarction as well as preparation method and application of bimodal imaging mediated treatment system
CN 114470242 A
申请人: GUANGZHOU MEGA MEDICAL BIOTECHNOLOGY CO LTD
优先权: 2022
CN
AGENT FOR PREVENTING OR AMELIORATING METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASES
WO 2025158806 A1
申请人: UNIV TOHOKU
优先权: 2024
WO
第 1 / 2 页
上一页
下一页
药物
反馈